X4 Pharmaceuticals Inc.
08/25/2025 | Press release | Distributed by Public on 08/25/2025 06:13
Management Change/Compensation (Form 8-K)
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 22, 2025, David McGirr and R. Keith Woods resigned from the board of directors (the "Board") of X4 Pharmaceuticals, Inc. (the "Company"), including all committees thereof, effective immediately. The resignations of Mr. McGirr and Mr. Woods from the Board are not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
In connection with the resignations of Messrs. McGirr and Woods, Michael Wyzga was appointed to serve as chair of the audit committee of the Board (the "Audit Committee") and Francoise de Craecker and Gary Bridger were appointed to serve as members of the Audit Committee.
X4 Pharmaceuticals Inc. published this content on August 25, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on August 25, 2025 at 12:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]